ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,837Medicare Part D Prescriptions Filled, Including Refills

Rank: 358 out of 3593

$664K Total Retail Price of All Prescriptions

Rank: 340 out of 3593

615 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

40% of this provider’s 615 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 615 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,993 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OXYCODONE HCL 773 129 S2 1 59
ALPRAZOLAM 513 277 2 37
SIMVASTATIN 486 388 3 1
LISINOPRIL 434 265 4 2
AMLODIPINE BESYLATE 382 223 5 3
IBUPROFEN 358 82 6 43
OXYCODONE HCL-ACETAMINOPHEN 355 176 S2 7 82
HYDROCODONE-ACETAMINOPHEN 290 157 S3 8 7
MORPHINE SULFATE ER 280 58 S2 9 108
TEMAZEPAM 249 179 10 56
LEVOTHYROXINE SODIUM 248 186 11 4
ATENOLOL 242 154 12 11
METFORMIN HCL 240 201 13 6
OXYCONTIN 232 33 S2 14 166
OMEPRAZOLE 223 147 15 5
HYDROMORPHONE HCL 216 40 S2 16 171
HYDROCHLOROTHIAZIDE 196 133 17 10
ZOLPIDEM TARTRATE 195 95 18 12
GABAPENTIN 183 85 19 16
METOPROLOL TARTRATE 173 92 20 8
FUROSEMIDE 158 103 21 9
CARVEDILOL 153 103 22 23
MORPHINE SULFATE 145 43 S2 23 240
ATORVASTATIN CALCIUM 143 110 24 15
FAMOTIDINE 136 68 25 70
AMOXICILLIN 126 43 26 128
GLIPIZIDE 120 99 27 40
WARFARIN SODIUM 117 93 28 18
ALENDRONATE SODIUM 104 89 29 22
ENDOCET 100 51 S2 30 206
CARISOPRODOL 94 33 R 31 97
CYCLOBENZAPRINE HCL 88 0 R 32 72
GEMFIBROZIL 88 53 32 88
OXYCODONE-ACETAMINOPHEN 84 57 S2 34 93
CRESTOR 80 73 35 21
CLONIDINE HCL 79 48 36 41
CIPROFLOXACIN HCL 78 51 37 52
TRAMADOL HCL 77 35 38 17
TAMSULOSIN HCL 74 44 39 33
VIAGRA 73 54 40 84
NAPROXEN 70 41 41 68
SERTRALINE HCL 70 29 41 28
LORAZEPAM 68 35 43 98
CLOPIDOGREL 67 44 44 30
AMLODIPINE BESYLATE-BENAZEPRIL 66 53 45 65
ALLOPURINOL 65 33 46 35
MELOXICAM 64 34 47 29
CITALOPRAM HBR 64 25 47 25
PAROXETINE HCL 59 58 49 62
FLUOXETINE HCL 58 33 50 60
GLIPIZIDE ER 55 36 51 101
PROAIR HFA 54 36 52 54
ENALAPRIL MALEATE 54 15 52 38
TRAZODONE HCL 54 25 52 53
TERAZOSIN HCL 54 45 52 115
GLYBURIDE 53 39 R 56 55
DOXAZOSIN MESYLATE 52 45 57 63
NEXIUM 52 22 57 36
POTASSIUM CHLORIDE 52 29 57 24
LOVASTATIN 50 18 60 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.